[This review was originally posted at the Nieman Journalism Lab on Nov. 22, 2013.] Expansion and questions for Playbook: Capital New […]
[This review was originally posted at the Nieman Journalism Lab Bactrim Price, on April 29, 2011.]
Leaking gets competitive: WikiLeaks made its first major document release in five months — during which time its founder, Julian Assange, was arrested, released on bail, and put under house arrest — this week, publishing 764 files regarding the Guantánamo Bay prison along with 10 media partners. (As always, The Nation's Greg Mitchell's WikiLeaks über-blogging is the place to go for every detail you could possibly need to know.)
That's more media partners than WikiLeaks has worked with previously, and it includes several first-timers, such as the Washington Post and McClatchy. As the Columbia Journalism Review's Joel Meares noted, Where can i buy Bactrim online, the list of partners doesn't include the New York Times and the Guardian, the two English-language newspapers who worked with WikiLeaks in its first media collaboration last summer. Despite being shut out, those two organizations were still able to force WikiLeaks' hand in publishing the leak, as the Huffington Post's Michael Calderone explained.
The Times got their hands on the documents independently, then passed them on to the Guardian and NPR, order Bactrim no prescription. This meant that, unlike the news orgs that got the info from WikiLeaks, they were operating without an embargo, Bactrim Price. As they prepared to publish last Sunday, WikiLeaks lifted its embargo early for its own partners (though the first to publish was actually the Telegraph, a WikiLeaks partner).
The New York Times' Brian Stelter and Noam Cohen said the episode was evidence that WikiLeaks "has become such a large player in journalism that some of its secrets are no longer its own to control." But, as they reported, Bactrim photos, WikiLeaks itself didn't seem particularly perturbed about it.
Patch's reaches for more bloggers: AOL seems to be undergoing a different overhaul every week since it bought the Huffington Post earlier this year, and this week the changes are at its hyperlocal initiative Patch, which is hoping to add 8,000 community bloggers to its sites over the next week or two in what its editor-in-chief called a "full-on course correction."
While talking to paidContent, AOL's folks played down the degree of change it's implementing, explaining that these new bloggers (who will be recruited from, Bactrim recreational, among other sources, the sites' frequent commenters) aren't disrupting the basic Patch model of one full-time editor per site. In fact, they'll be unpaid, something that's been a bit of a headache for AOL and HuffPo lately.
Business Insider's Nicholas Carlson liked the plan Bactrim Price, , saying volunteer bloggers can become "extremely effective word-of-mouth marketers" and "excellent pageview machines" with, of course, "manageable" salaries. Bactrim class, Others from MediaBistro and Wired were a little more skeptical of the no-pay factor. Lehigh j-prof Jeremy Littau took issue with a more systemic aspect of the new blogs, which will exist both on the writer's own site and on Patch. Splitting up the conversation with that arrangement won't be helpful for the individual blogs or for the local blogosphere as a whole, he said: "I see something developing that leads to less population in the local blogosphere and a walled-off system that operates on Patch. At worst, it will lead to parallel and fracture conversations online, which is death when we’re talking about hyperlocal."
Two new media manifestos: Two New York j-profs — and two of the more prominent future-of-news pundits online these days — both published manifestos of sorts this week, effects of Bactrim, and both are worth a read. Jay Rosen summed up what he's learned about journalism in 25 years of teaching and thinking about it at NYU, and CUNY's Jeff Jarvis gave a few dozen bullet points outlining his philosophy of news economics.
Rosen's post touched on several of the themes that have colored his blog and Twitter feed over the past few years, including the value of increasing participation, the failure of "objectivity," and the need for usefulness and context in news, Bactrim Price. But the ideas weren't exactly new, the conversation they generated was stimulating. Bactrim interactions, The comments chase down some interesting tangents, and GigaOM's Mathew Ingram expanded on Rosen's point about participation, arguing that even if the number of users who want to participate is relatively low, opening up the process can still be immensely important in improving journalism. Rosen also inspired TBD's Steve Buttry to write his own "what I know about news" post.
Like Rosen's post, Jarvis' wouldn't break a whole lot of ground for those already familiar with his ideas, my Bactrim experience, but it summed them up in a helpfully pithy format. Bactrim Price, He focused heavily on providing real value ("The only thing that matters to the market is value"), the importance of engagement, and finding efficiencies in infrastructure and collaboration. His post contains plenty of pessimism about the current newspaper business model, and Mathew Ingram and FishbowlNY's Chris O'Shea defended him against the idea that he's just a doomsayer.
Times paywall bits: The New York Times spent a reported $25 million to develop its paid-content system, and it will be spending another $13 million on the plan this year, Bactrim without prescription, mostly for promotion. Women's Wear Daily detailed those promotional efforts, which include posters around New York as well as TV spots. PaidContent's Robert Andrews compared the Times' pay plan to that of theother Times (the one in London, owned by Rupert Murdoch), noting that the New York Times' plan should allow them to draw more revenue while maintaining their significant online influence, something the Times of London hasn't done at all (though it's largely by choice), Bactrim from canadian pharmacy.
Meanwhile, Terry Heaton found another (perhaps more convoluted) way around the Times' system, tweeting links to Times stories that he can't access, Bactrim Price. And elsewhere at the Times, the Lab's Megan Garber explored the Times' R&D Lab's efforts to map the way Times stories are shared online.
And elsewhere in paywalls, the CEO of the McClatchy newspaper chain has reversed his anti-paywall stance and said this week the company is planning paywalls for some of its larger papers, and Business Insider introduced us to another online paid-content company, Buy Bactrim online no prescription, Tiny Pass.
Apps, news, and pay: In his outgoing post on Poynter's Mobile Media blog, Damon Kiesow had a familiar critique for news organizations' forays into mobile media — they're too much like their print counterparts to be truly called innovative. But he did add a reason for optimism, pointing to the New York Times' News.me and the Washington Post's Trove: "Neither is a finished product or a perfect one, get Bactrim. But both were created by newspaper companies that put resources into research and development."
Media analyst Ken Doctor said Bactrim Price, local news needs to start moving toward mobile media to reach full effectiveness, laying out the model of an aggregated local news app pulling various types of media. For maximum engagement, that app had better include audio, according to some NPR statistics reported by the Lab's Andrew Phelps.
There may a bigger place for paid apps than we've thought: Instapaper's Marco Arment twice pulled the free version of the app for about a month and found that sales actually increased. He made the case against free apps, Kjøpe Bactrim på nett, köpa Bactrim online, saying they bring low conversion rates, little revenue, and unnecessary image problems. Meanwhile, makers of one free app, Zite, said they're releasing a new version to deal with complaints they've been getting from publishers about copyright issues, about Bactrim.
Reading roundup: No big stories this week, but tons of little things to keep up on, Bactrim Price. Here's a bit of the basics:
— On social media: Facebook launched a "Send" plugin among a few dozen websites (including a couple of news sites) that allows private content-sharing. The Next Web's Lauren Fisher argued that journalists should spend more time using Facebook, and Canadian j-prof Alfred Hermida wrote about a study he helped conduct about social media and news consumption.
— The Guardian shut down a local-news project it launched last year, saying the local blogs were "not sustainable." PaidContent's Robert Andrews said that while the blogs were useful, Bactrim cost, there are few examples of sustainable local-news efforts, and Rachel McAthy of Journalism.co.uk rounded up some opinions to try to find the value in the Guardian's experiment.
— The news filtering program launched in public beta this week, prompting a New York Times profile and pieces by GigaOM's Mathew Ingram and the Knight Digital Media Center's Amy Gahran on the journalistic value of curation.
— Thanks to its most recent content-farm-oriented algorithm tweak, Google's traffic to all Demand Media sites is down 40%, which caused Demand stock to slide this week. Google, meanwhile, added some more automatic personalization features to Google News.
— The Lab's Andrew Phelps wrote a great piece expounding on the journalistic utility of the humble (well, kind of humble) smartphone.
— And for your deep-thinking weekend-reading piece, Harvard researcher Ethan Zuckerman's thoughtful take on overcoming polarization by understanding each other's values, rather than just facts.
Similar posts: Flagyl Price. Order Zoloft. Purchase Tramadol. Buy Cephalexin online cod. Cephalexin long term. Cipro use.
Trackbacks from: Bactrim Price. Bactrim Price. Bactrim Price. Bactrim natural. Buy Bactrim without a prescription. Doses Bactrim work.
[This review was originally posted at the Nieman Journalism Lab Purchase Lipitor, on March 18, 2011.]
First reactions to The Times' paid-content plans: Yesterday The New York Times rolled out the online paid-content plans they've been talking about for a little more than a year. You get 20 articles a month for free (besides the ones you get to through Google and social media), and after that it's going to cost you anywhere from $15 to $35 per four weeks, depending on what devices you want to access it on. Print subscribers will get it all for free. (Yup, as the Lab's Josh Benton and Forbes' Jeff Bercovici pointed out, that means there are print plans with online access that are cheaper than the online-only ones.) Subscriptions will sold, Lipitor results, among other places, in Apple's iTunes store. Here's The Times' letter to readers and news article, as well as the Lab's glimpse at the paywall and a good paidContent FAQ.
Now for the reaction and analysis: If you only have time for a few pieces, make them Ken Doctor, Steve Outing, and Felix Salmon, Purchase Lipitor. If you want a quick sampler platter of opinions, you can't do any better than the Lab's roundup of 11 experts' thoughts.
There was no consensus of initial opinion about the plan; many supporters spoke up quickly, including The Times' own media critic, David Carr, purchase Lipitor, and The Daily Beast's Howard Kurtz. Poynter newspaper analyst Rick Edmonds broke down the ways it met all the initial criteria of a sound paywall plan, and British j-prof Paul Bradshaw called it "the most mature, intelligent, and commercially sensible paywall model yet," praising its respect for distribution and online engagement. At The Columbia Journalism Review, Lipitor over the counter, Ryan Chittum said it looked good, and Lauren Kirchner issued a rejoinder to the "information wants to be free" crowd. Purchase Lipitor, The Times' detractors were quick to speak up, too. Media analyst Steve Outing laid out most of the basic objections: The prices are too high, people will turn away when they hit the 20-article limit, and the differentiation by device doesn't make sense. (TechCrunch's Erick Schonfeld harped on the latter point, too.) Reuters' Felix Salmon chimed in by saying that the price point is high enough that a lot of regular readers won't subscribe (meaning the plan won't bring in much revenue anyway), and that the Times is discouraging use of its iPad.
At BoingBoing, Lipitor forum, Cory Doctorow said most users will find the metering system frustrating, leading them to find other ways to read The Times or just not read it at all. Techdirt's Mike Masnick made a similar point, adding that The Times isn't adding any value with the plan. That was tech pioneer Dave Winer's main beef: "They're not offering anything to readers other than the Times' survival, and they're not even explicit about that."
Plenty of commentary didn't fall into either the "pro" or "con" camp, of course, Purchase Lipitor. Here at the Lab, Ken Doctor provided the definitive economic analysis of the plan, breaking down the seven tests it must pass to be successful. Discount Lipitor, Then there was the issue of getting around the paywall (or, as Doctor more accurately called it, the fence): Business Insider told us how to do it via Google, and TechCrunch pontificated on the social media loophole that will develop in addition to the current Google one. Media consultant Steve Yelvington downplayed that factor: "It's not supposed to be a bank vault, people. It's a polite request for payment."
Another obvious next question is whether this could be applied to other news organizations. Purchase Lipitor, Meranda Watling of 10,000 Words compared the plan with those of The Wall Street Journal and Newsday, but Amy Gahran of the Knight Digital Media Center gave other newspapers a stern "don't try this at home."
Breaking down an old debate at SXSW: Just as they do every March, geeks descended on Austin, Texas, last weekend for the South by Southwest Interactive Festival, and as usual, there was plenty of journalism-related stuff to chew on, even for those of us who didn't attend. The session that seemed to get the most traction online was NYU professor Jay Rosen's psychological analysis of the tension between bloggers and journalists — which is perhaps a bit surprising for a battle that Rosen himself declared "over" six years ago.
Rosen's whole talk is worth a read, online buy Lipitor without a prescription, but here's the gist of it: For journalists, bloggers are the idealized face of all the ideological and professional stresses they deal with, and for bloggers, the conflict helps keep them on the "outside" of the system, allowing them to maintain their innocence and rhetorical power. Snarkmarket's Matt Thompson and Tim Carmody liveblogged their analysis of the talk, and The Guardian summarized it. Lipitor pics, Michele McLellan of the Knight Digital Media Center ripped blogger-hating journalists for fighting an outdated war, but Melissa Bell of the Washington Post called Rosen's characterization of objectivity misleading.
There were plenty of other panels worth reading about, too, including NYU prof Clay Shirky's timely talk on social media and revolution, in which he said that governments routinely overestimate our access to information and underestimate our access to each other, Purchase Lipitor. (The Guardian had a short summary, and Poynter's Julie Moos put together a blow-by-blow in Storify.)
There were also a couple of panels on the value of gaming, particularly in news, as well as sessions on building trust online, using social media to evade censorship, the future of public media, iPad news apps, is Lipitor safe, and SEO tips from Google and Bing. Poynter's Steve Myers pulled together a dozen journalists for an overview of the conference in terms of building community, and an Economist blogger tied this year's SXSW to last year's with a sharp post questioning the story as the basic unit of journalism.
A critical eye on NPR's antagonists: The damage to NPR from James O'Keefe's hidden-camera exposé was already done last week, but the scrutiny of the tape itself didn't begin in earnest until the weekend — kicked off by, of all places, Glenn Beck's website, Lipitor from canada, The Blaze. (Time's James Poniewozik's breakdown is also worth a read.) The site's skepticism of the video's editing was picked up by NPR media reporter David Folkenflik, who examined the issue in a broadcast report. NPR's spokeswoman called the video Purchase Lipitor, "inappropriately edited," but said the executive in the tape had still made "egregious statements."
Whatever O'Keefe's ethics, Poynter's Steve Myers said, there's plenty he understands about today's media environment that we can learn from: Investigative journalism is in demand, raw media communicates "reality," and soundbites and reducing opponents' logic to absurdities trump context in the online media world.
The change in leadership at NPR prompted others to look at the health and direction of the organization overall: The New York Times' David Carr examined NPR's success in light of the public-funding argument, and Poynter's Mallary Jean Tenore laid out the four biggest challenges for NPR's next CEO. The Lab's Nikki Usher looked overseas for public media comparisons, and The Columbia Journalism Review talked to Jonathan Holmes of the Australian Broadcasting Corporation about the public media situation there.
A snapshot of the state of journalism: Pew's Project for Excellence in Journalism released its annual State of the Media report this week, summarizing last year as a good one for journalism. The big headline that most media outlets took away from the study was that for the first time, online news consumption has surpassed newspaper use. There were plenty of other nuggets from the study, though, covering a variety of news media.
The study outlined the state of the newspaper industry, touching on all the major themes from circulation to advertising to digital paid-content efforts, Purchase Lipitor. One of the authors of that part of the study, Poynter's Rick Edmonds, Lipitor overnight, summarized the trends he found interesting.
It also included a look at the economics of startup community journalism, with discussion of nonprofits, ad-based sites, and the Patch model. (Author Michele McLellan summarized her main points here.) The researchers also reported on a survey on mobile news use, and Amy Gahran of the Knight Digital Media Center and Damon Kiesow of Poynter highlighted some of the opportunities for news organizations in its results.
A couple of other tidbits from the study: Search Engine Land's Vanessa Fox focused on revenue from advertising, subscriptions, Lipitor alternatives, and mobile apps, and j-prof Alfred Hermida pointed out the difference between the news agendas of Twitter, blogs and the mainstream media.
Twitter tells developers to hold off: Twitter made waves in the tech world late last week when they posted a note Purchase Lipitor, telling developers not to develop any more Twitter clients, saying they'd like to do it themselves, ostensibly for consistency's sake. (Mashable has a great explanation of the issue.) Most of the initial reaction was not enthusiastic: Salon's Dan Gillmor said the note was a reminder that we need other options for our online platforms that aren't controlled by a single company, and Dave Winer said it reinforces the fact the open web is the best place to develop.
Mathew Ingram of GigaOM and developer Fred Oliveira both urged Twitter to rethink its decision, noting that third-party apps like Tweetdeck and Tweetie spurred much of Twitter's initial growth. Lipitor without prescription, And ReadWriteWeb's Marshall Kirkpatrick saw this as a hint at where Twitter is headed culturally: "If you thought Twitter was a place for outlaws, for free thinkers, for innovators - you need to tuck in your shirt, cut your hair and get a clue."
Others, however, defended Twitter: Social media marketer Jesse Stay said he wishes Twitter had done this a while ago, and developer Rob Diana argued that Twitter has finally given developers a solid sense of direction while still giving them some freedom.
Reading roundup: A few notes to digest while your bracket goes up in flames:
— The big news story of the past week has been the earthquake, tsunami and their aftermath in Japan, Lipitor online cod. There wasn't a whole lot written about it from a media perspective, but there were a couple of insightful posts, Purchase Lipitor. Doc Searls looked at coverage and concluded that the web is subsuming TV and radio, and Jeff Jarvis asked for separate Twitter hashtags for breaking news event witnesses.
— A few leftover AOL/Huffington Post items: GigaOM's Mathew Ingram looked at why AOL is desperate for some successful content initiatives, Arianna Huffington talked SEO, TechCrunch broke down the journalism/churnalism tension at AOL, and The New York Times' Bill Keller issued a non-apology followup to his Huffington-bashing essay last week.
— A couple of stray items from the commenting discussion of the last couple of weeks: Via O'Reilly Radar, Effects of Lipitor, statistics showing the integration of Facebook Comments led to fewer comments at TechCrunch, and a defense of anonymous commenting from Paul O'Flaherty.
— Finally, the Lab has the transcript of an interesting talk Northwestern prof Pablo Boczkowski gave about the gap between what news consumers want and what they get, with a thoughtful response from the Lab's Josh Benton. Enjoy.
Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Purchase Lipitor. Purchase Lipitor. Purchase Lipitor. Lipitor results. Lipitor street price. Generic Lipitor.
[This review was originally posted at the Nieman Journalism Lab Lipitor Mg, on Sept. 17, 2010.]
Entrepreneurship and old-school skills in j-school: We found out in February that New York University and the New York Times would be collaborating on a news site focused on Manhattan's East Village, and this week the site went live. Journalism.co.uk has some of the details of the project: Most of its content will be produced by NYU students in a hyperlocal journalism class, though their goal is to have half of it eventually produced by community members. NYU professor Jay Rosen, an adviser on the project, got into a few more of the site's particulars, effects of Lipitor, describing its Virtual Assignment Desk, which allows local residents to pitch stories via a new WordPress editing plugin.
Rosen's caution that "it is going to take a while for The Local East Village to find any kind of stride" notwithstanding, the site got a few early reviews. The Village Voice's Foster Kamer started by calling the site the Times' "hyperlocal slave labor experiment" and concluded by officially "declaring war" on it, Lipitor Mg. GigaOM's Mathew Ingram, on the other hand, was encouraged by NYU's effort to give students serious entrepreneurial skills, Where can i cheapest Lipitor online, as opposed to just churning out "typists and videographers."
NYU's project was part of the discussion about the role of journalism schools this week, though. PBS' MediaShift wrapped up an 11-post series on j-school, which included an interview with Rosen about the journalism as R&D lab and a post comparing and contrasting the tacks being taken by NYU, Jeff Jarvis' program at the City University of New York and Columbia University. (Unlike the other two, Columbia is taking a decidedly research-oriented route.) Meanwhile, Tony Rogers, a Philadelphia-area j-prof, Lipitor steet value, wrote two articles (one of them a couple of weeks ago) at About.com quoting several professors wondering whether journalism schools have moved too far toward technological skills at the expense of meat-and-potatoes journalism skills.
They weren't the only ones: Both Teresa Schmedding of the American Copy Editors Society and Iowa State j-school director Michael Bugeja also criticized what they called a move away from the core of journalism in the country's j-schools. Lipitor Mg, "I expect to teach new hires InDesign, Quark or Twitter, MySpace, FB and how to use whatever the app of the week is, but I don’t expect to teach you what who, what, where, when, why and how means," Schmedding wrote. TBD's Steve Buttry countered those arguments with a post asserting that journalists need to know more about disruptive technology and what it's doing to their future industry. "Far too many journalists and journalism school graduates know next to nothing about the business of journalism and that status quo is indefensible," said Buttry.
A turning point in news consumption: Like most every Pew survey, the biennial study released this week by the Pew Center for the People & the Press is a veritable cornucopia of information on how people are consuming news. Tom Rosenstiel of Pew's Project for Excellence in Journalism has some fascinating musings of the study's headline finding: People aren't necessarily ditching old platforms for news, Buy Lipitor online no prescription, but are augmenting them with new uses of emerging technology. Rosenstiel sees this as a turning point in news consumption, brought about by more tech-savvy news orgs, faster Internet connections, and increasing new media literacy. Several others — Mathew Ingram of GigaOM, Joe Pompeo of Business Insider, Chas Edwards of Digg — agreed that this development is a welcome one.
The Washington Post's Howard Kurtz and paidContent's Staci Kramer have quick summaries of the study's key statistics, and DailyFinance's Jeff Bercovici pointed out one particularly portentous milestone: For the first time, the web has eclipsed newspapers as a news source, Lipitor Mg. (But, as Collective Talent noted, comprar en línea Lipitor, comprar Lipitor baratos, we still love our TV news.) Lost Remote's Cory Bergman took a closer look at news consumption via social media, and j-prof W. Joseph Campbell examined the other side of the coin — the people who are going without news.
The Pew Internet & American Life Project also released an interesting study this week looking at "apps culture," which essentially didn't exist two years ago. Beyond the Book interviewed the project's director, Lee Rainie, Lipitor cost, about the study, and the Lab gave us five applications for news orgs from the study: Turns out news apps are popular, people will pay for apps, and they consume apps in small doses.
Did social media kill RSS and press releases?: Ask.com announced last Friday Lipitor Mg, that it would shut down Bloglines, the RSS readerit bought in 2005, citing a slowdown in RSS usage as Twitter and Facebook increase their domination of real-time information flow. "The writing is on the wall," wrote Ask's president, Doug Leeds. PaidContent's Joseph Tarkatoff used the news as a peg for the assertion that the RSS reader is dead, noting that traffic is down for Bloglines and Google Reader, Lipitor coupon, and that Google Reader, the web's most popular RSS reader, is being positioned as more of a social sharing site.
Tech writer Jeff Nolan agreed, arguing that RSS has value as a back-end application but not as a primary news-consumption tool:"RSS has diminishing importance because of what it doesn’t enable for the people who create content… any monetization of content, brand control, traffic funneling, Cheap Lipitor, and audience acquisition," he wrote. Business Insider Henry Blodget joined in declaring RSS readers toast, blaming Twitter and Facebook for their demise. Numerous people jumped in to defend RSS, led by Dave Winer, who helped invent the tool about a decade ago, Lipitor Mg. Winer argued that RSS "forms the pipes through which news flows" and suggested reinventing the technology as a real-time feed with a centralized, non-commercial subscription service.
Tech writer Robert Scoble responded that while the RSS technology might be central to the web, RSS reading behavior is dying. The future is in Twitter and Facebook, Lipitor brand name, he said. GigaOM's Mathew Ingram and media consultant Terry Heaton also defended RSS, with Ingram articulating its place alongside Twitter's real-time flow and Heaton arguing that media companies just need to realize its value as its utility spreads across the web.
RSS wasn't the only media element declared dead this week; Advertising Age's Simon Dumenco also announced the expiration of the press release Lipitor Mg, , replaced by the "real-time spin of Facebook and Twitter. PR blogger Jeremy Pepper and j-prof Kathy Gill pushed back with cases for the press release's continued use.
Twitter's media-company move: Lots of interesting social media stuff this week; I'll start with Twitter. The company began rolling out its new main-page design, which gives it a lot of the functions that its independently developed clients have. Lipitor maximum dosage, Twitter execs said the move indicated Twitter's status as a more consumptive platform, where the bulk of the value comes from reading, rather than writing — something All Things Digital's Peter Kafka tagged as a fundamental shift for the company: "Twitter is a media company: It gives you cool stuff to look at, you pay attention to what it shows you, and it rents out some of your attention to advertisers."
GigaOM's Mathew Ingram and venture capitalist David Pakman agreed, with Pakman noting that while Google, Facebook and Twitter all operate platform, users deal overwhelmingly with the company itself — something that's very valuable for advertisers. The Lab's Megan Garber also wrote a smart post on the effect of Twitter's makeover on journalism and information, Lipitor Mg. The new Twitter, generic Lipitor, Garber writes, moves tweets closer to news articles and inches its own status from news platform closer to a broadcast news platform. Ex-Twitter employee Alex Payne and Ingram (who must have had a busy week) took the opportunity to argue that Twitter as a platform needs to decentralize.
On to Facebook: The New Yorker released a lengthy profile of Facebook founder Mark Zuckerberg, and while not everyone was crazy about it (The Atlantic's Alexis Madrigal thought it was boring and unrevealing), but it gave the opportunity for one of the people quoted in it —Expert Labs director Anil Dash — to deliver his own thoughtful take on the whole Facebook/privacy debate. Dash isn't that interested in privacy; what he is worried about is "this company advocating for a pretty radical social change to be inflicted on half a billion people without those people's engagement, Lipitor street price, and often, effectively, without their consent."
Elsewhere around social media and news: Mashable's Vadim Lavrusik wrote a fantastic overview of what news organizations are beginning to do with social media, and we got closer looks at PBS NewsHour, DCist and TBD in particular.
Reading roundup Lipitor Mg, : Plenty of stuff worth reading this week. Let's get to it.
— Last week's discussion on online traffic and metrics spilled over into this week, as the Lab's Nikki Usher and C.W. Anderson discussed the effects of journalists' use of web metrics and the American Journalism Review's Paul Farhi looked at the same issue (from a more skeptical perspective), Lipitor for sale. The Columbia Journalism Review's Dean Starkman had the read of the week on the topic (or any topic, really), talking about what the constant churn of news in search of new eyeballs is doing to journalism. All of these pieces are really worth your time, Lipitor Mg.
— The San Jose Mercury News reported that Apple is developing a plan for newspaper subscriptions through its App Store that would allow the company to take a 30 percent cut of all the newspaper subscriptions it sells and 40 percent of their advertising revenue. The Columbia Journalism Review's Ryan Chittum was skeptical of the report, but Ken Doctor had nine good questions on the issue while we find out whether there's anything to it.
— The Atlantic published a very cool excerpt from a book on video games as journalism by three Georgia Tech academics. Where can i order Lipitor without prescription, I'm guessing you'll be hearing a lot more about this in the next couple of years. Lipitor Mg, — Rafat Ali, who founded paidContent gave a kind of depressing interview to Poynter on his exit from the news-about-the-news industry. "I think there’s just too much talk about it, and to some extent it is just an echo chamber, people talking to each other. There's more talk about the talk than actual action." Well, shoot, I'd better find a different hobby. (Seriously, though, purchase Lipitor online no prescription, he's right — demos, not memos.)
— Finally, a wonderful web literacy tool from Scott Rosenberg: A step-by-step guide to gauge the credibility of anything on the web. Read it, save it, use it.
Similar posts: Cephalexin Over The Counter. Armour Mg. Purchase Glucophage. Flagyl dangers. Herbal Diflucan. Order Tramadol no prescription.
Trackbacks from: Lipitor Mg. Lipitor Mg. Lipitor Mg. Buy no prescription Lipitor online. Lipitor steet value. Taking Lipitor.
[This review was originally posted at the Nieman Journalism Lab Tramadol Dosage, on June 18, 2010.]
The FTC's last round of input: The U.S. Federal Trade Commission wrapped up its series of forums on journalism and public policy Tuesday, and this forum got quite a bit more attention than the others — partly because it's the last one, and partly because the FTC released its draft of possible policy proposals a few weeks ago, which gave people something concrete to pick apart.
Before the forum, Tramadol use, The New York Times' Jeremy Peters and TBD's Steve Buttry both gave good summaries of what various people are saying about the issue, and Save the News' Fiona Morgan gave a helpful, detailed description of what went on at the forum itself. As for the FTC's final report due out this fall, Poynter's Rick Edmonds and Bloomberg Businessweek's Olga Kharif both wrote that we're unlikely to see any proposals for significant government intervention in the news business. Edmonds offers a handful of reasons that the idea has fallen out of favor: Newspapers' financial fortunes have improved lately, we've seen an explosion of strongly backed digital journalism experiments, Tramadol wiki, the government might not be able to do it well, and news organizations themselves aren't sure what they want from Uncle Sam. Both Edmonds and Kharif also noted that Congress won't be willing to be seen as bailing out another for-profit industry.
A few more voices — media economics professor Robert Picard, TBD's Mandy Jenkins and conservative Denver Post columnist David Harsanyi — joined the anti-subsidy chorus this week, and the Times' Eric Pfanner provided some evidence to back them up, pointing out that countries with the largest direct subsidies for newspapers also have the lowest newspaper readership, Tramadol Dosage. (He also noted the U.S. media's extreme reliance on advertising compared with the rest of the world.)
Other folks offered a few ideas of what policy proposals they'd like to see the FTC endorse. Edmonds wants to see nonprofits allowed to accept advertising, Buy Tramadol from mexico, j-prof C.W. Anderson says public policy has a role in "fostering an entrepreneurial, innovative, reinvented journalistic sphere," Salon's Dan Gillmor stumps for open broadband subsidies, and Save the News' Josh Stearns lists five ideas he wants endorsed. Tramadol Dosage, The themes that run across several of those people's proposals are clear: Net neutrality, expanded broadband, open government data, and encouragement for innovation, rather than protection for traditional media businesses.
Google News goes human: One low-key but potentially significant development from late last week: As the Lab's Megan Garber reported, after Tramadol, Google News began an experiment called Editors' Picks, in which editors from partner news organizations like the BBC and the Washington Post curate lists of news articles to go along with Google's algorithm-run selections. Garber notes what a shift this is from Google's historical approach to news aggregation and ties it to the quest for serendipity: "This is one way of replicating the offline experience of serendipity-via-bundling within the sometimes scattered experience of online news consumption," she says.
GigaOM's Mathew Ingram saw in the project a similar sign of a shift toward human-powered news aggregation at Google, No prescription Tramadol online, though he noted that Google has tried numerous news-related experiments that never caught on. That's exactly what a Google spokesperson told paidContent's Staci Kramer, and both sites mentioned Google's ill-fated commenting experiment as an example.
Still, Mashable's Vadim Lavrusik loved this idea, making a case for the value of human editors in making sure that people are reading what they need to know online as well as what they want to know, Tramadol Dosage. In other Google News news, its creator, Krishna Bharat, gave a long interview in which he discussed its role in journalism and his idea of what the future of journalism might look like, buy Tramadol without prescription.
Murdoch picks up some paid-content pieces: Rupert Murdoch's News Corp. continued its long, steady march toward a paid-news future with a few small but potentially important moves this week: It bought the Skiff mobile software platform from the newspaper chain Hearst — not the Skiff e-reader itself, though it seems they're working on that — invested in Journalism Online, Steve Brill's news paid-content venture, and bid to take full control of British Sky Broadcasting, Europe's largest for-pay broadcaster.
Hollywood Reporter's Andrew Wallenstein called the first two moves huge news for the digital news business, arguing that Murdoch is setting the standard for the way everyone else does business online. "This is about laying the groundwork for the very process by which people pay for that news; namely, the device they consume it on and the virtual storefront that handles the payment, is Tramadol safe," he wrote. Tramadol Dosage, And with BSkyB's digital music and broadband services, it looks like Murdoch's hoping to add another major asset in his plans to find new ways to get people to pay for not only news, but digital entertainment media as well.
A theory of the political press defined: If you've been following NYU professor Jay Rosen on Twitter or reading his blog for any length of time, you've probably absorbed a general sense of his guiding philosophy about the American political press. But this week he posted the definitive explanation of that philosophy, which is most simply that political journalists' prevailing ideology is one of false equivalency between two sides of political extremists, Tramadol no prescription, while they (and their favorite politicians) stand at the sane, savvy, skeptical center. It's obviously just one critic's opinion, but it's a remarkably helpful frame to help interpret what the Washington press corps values and why it does what it does.
There's some fascinating discussion about Rosen's ideas in the lengthy comments of his post, and he got a few thoughtful responses elsewhere, as well, Tramadol no rx. The Atlantic's Conor Friedersdorf agreed with the main thrust of Rosen's argument, though he challenged the assertion that political journalists are "big believers in the law of unintended consequences" who don't pay much attention to the direct consequences of public policy. The Economist likewise endorses the post but counters that Rosen's concepts of "he said, she said journalism" and "the sphere of deviance" are at odds, Tramadol Dosage. Over at Slate, Tom Scocca affirms a point of Rosen's about journalists' disregard for street protests, and Australian journalist Jonathan Holmes adapted the concept to the Australian media. Doses Tramadol work, Also, the Atlantic's Marc Ambinder — as a political editor, part of the tribe Rosen was dissecting — asked the professor what he would have the political press think instead. Rosen has promised an answer.
Future-of-news thoughts and innovation: Before we get to the reading roundup, a note on a couple of interesting items that the Lab has been highlighting this week. Tramadol Dosage, First, our sister publication, Nieman Reports, has published its quarterly issue, which is always chock-full of thought-provoking essays on journalism in transition. This summer's issue is titled "What's Next for News?" so it's right along the lines of the stuff we write about here at the Lab, where can i order Tramadol without prescription. The Lab has been pointing out several of the issue's 36 pieces — including thoughts on the Internet's effects on our thinking, the editor-as-gatekeeper role, and the semantic web — but there's plenty more out there, so go look around.
Second, Buy cheap Tramadol no rx, the Knight News Challenge announced the 12 winners of its $2.74 million worth of grants for innovative journalism projects. The Lab's Josh Benton has a rundown of the winners and a few observations about the crop as a whole, and we've got profiles of a few of the initiatives, too. There's Stroome, the wiki-style collaborative video-editing site; Public Radio Exchange, a crowdfunding project for public radio journalism; and Order in the Court 2.0, an effort to open up courtrooms through new media, Tramadol Dosage. They should have several more profiles up over the next few days (probably even before this post is published) if you're in the mood to be encouraged by innovation in news.
Reading roundup: Two ongoing discussions, one news economics development, Tramadol gel, ointment, cream, pill, spray, continuous-release, extended-release, and one thoughtful piece on context:
— Two news economics experts, Alan Mutter and Frederic Filloux, weighed in this week with their assessments of iPad news apps so far. Mutter looks at the winners and losers, and Filloux talks about what makes iPad news apps work. Online buying Tramadol, — We've been hearing for a couple of weeks about what the Internet is (or isn't) doing to our brains, and that conversation continued with a defense of the web by The New York Times' Nick Bilton a caution to doomsayers by psychology professor Steven Pinker.
— Consulting firm PricewaterhouseCoopers estimated this week that Internet ad revenue will surpass newspaper ad revenue by 2014. Both will still remain behind TV ad revenue, they said.)
— Finally, former journalist John Zhu wrote a wonderful explanation of the state of, well, explanation in the news. (Complete with helpful visual aids!) If you're interested at all in how journalists can make complex stories more understandable to people, this is the perfect place to start putting together where we've been and where we could be going.
Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Tramadol Dosage. Tramadol Dosage. Tramadol Dosage. Tramadol class. Tramadol pics. Tramadol trusted pharmacy reviews.